Molecular Therapy · 2012 · 248 citations · 38 references
Life SciencesImmunologyOncologyCancer ImmunologyImmunotherapyTumor ImmunologyAntitumor T Cell ResponsesCancer ImmunotherapyChimeric Antigen Receptor T-cell TherapyImmunotherapy For Brain TumorsT Cell Responses To TumorsTumor AntigensCd28 SignalingEpidermal Growth Factor Receptor Targeting LigandsGlioblastoma Targeted TherapyHer2 Receptor TargetingHuman Epidermal Growth Factor Receptor 2 (Her2) ExpressionHuman Epidermal Growth Factor Receptor 2-Targeted TherapyT Cell-based ImmunotherapyTumor Cell Selectivity
38
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21.6K citations · Full text
Roger Stupp, Monika E. Hegi, Warren Mason et al. · The Lancet Oncology · 2009 · 7.8K citations
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao, Qiulian Wu, Roger E. McLendon et al. · Nature · 2006 · 6.4K citations
Medicine, Cancer Biology, Oncology +16
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter, Bruce L. Levine, Michael Kalos et al. · New England Journal of Medicine · 2011 · 3.5K citations · Full text